Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 10,441-10,452 of 23,847
Device study icon
CompletedNCT05688891

Burn Patient Care, Virtual Reality, Music, Pain, Anxiety and Pain Anxiety

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.

In Istanbul
AnxietyOtherFrom 18 Years to 65 Years
Countries
Türkiye
Sponsor
Karabuk University
Condition
Anxiety
Behavioral study icon
CompletedNCT05248217

Burnout, Covid 19, Smarthphone Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In Rize
AddictionBehavioral
Countries
Türkiye
Sponsor
Kutahya Health Sciences University
Condition
Addiction
Behavioral study icon
CompletedNCT04807517

Buspirone Treatment of Anxiety in Williams Syndrome

This summary needs review. Please check the official study record and contact the research team for details.

In Lexington
AnxietyBehavioralFrom 5 Years to 65 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Anxiety
Drug study icon
CompletedNCT02132832

Buspirone, Stress, and Attentional Bias to Marijuana Cues

This summary needs review. Please check the official study record and contact the research team for details.

In Houston
AddictionDrugFrom 18 Years to 45 Years
Countries
United States
Sponsor
The University of Texas Health Science Center, Houston
Condition
Addiction
Drug study icon
CompletedNCT03708315

BXCL501 for Agitation in Schizophrenia

This study exists to better understand the safety of a medication treatment and how manageable it feels in practice. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

In New Haven
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Yale University
Condition
Schizophrenia
Drug study icon
TerminatedNCT05662306

C-Cog in Early Course Schizophrenia Study

This study exists to explore whether this type of care could improve care and understanding. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.

In Miami
SchizophreniaDrugOver 18 Years
Countries
United States
Sponsor
University of Miami
Condition
Schizophrenia
Other study type icon
Enrolling By InvitationNCT06838468

cACLD in people with Addiction in the Hospital Detoxification Unit

This summary needs review. Please check the official study record and contact the research team for details.

In Sabadell
AddictionDiagnostic TestA study that looks at how to detect, measure, or better understand a condition.From 18 Years to 75 Years
Countries
Spain
Sponsor
Corporacion Parc Tauli
Condition
Addiction
Behavioral study icon
CompletedNCT06061952

CAE for Poorly Adherent Individuals With Schizophrenia

This study exists to see whether questionnaires and follow-up reports is workable and worth testing more broadly. Researchers are trying to understand whether questionnaires and follow-up reports can make support easier to access outside standard clinic visits.

In Cleveland
SchizophreniaBehavioralOver 18 Years
Countries
United States
Sponsor
University Hospitals Cleveland Medical Center
Condition
Schizophrenia
Behavioral study icon
CompletedNCT03408873

CAE Plus LAI in Individuals With Bipolarity at Risk for Treatment Non-adherence (BD-CAEL)

This study exists to see whether psychoeducation, a guided learning and support program, can play a useful role in care. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can work better when mental health difficulties overlap with substance use.

In Cleveland
BipolarityBehavioralOver 18 Years
Countries
United States
Sponsor
Martha Sajatovic
Condition
Bipolarity
Drug study icon
CompletedNCT00034892

CAFE Comparison of Atypicals in First Episode of Psychosis

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Stanford
SchizophreniaDrugFrom 16 Years to 40 Years
Countries
United States, Canada
Sponsor
AstraZeneca
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.